Cargando…

Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans

CONTEXT: The gut microbiome is a source of inflammatory factors such as lipopolysaccharide (LPS; endotoxin) that influence metabolic homeostasis. Rifaximin is a well-tolerated antibiotic that may reduce LPS. OBJECTIVE: We sought to develop a method to accurately assess postprandial endotoxemia and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Finlin, Brian S, Zhu, Beibei, Boyechko, Tania, Westgate, Philip M, Chia, Chee W, Egan, Josephine M, Kern, Philip A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691337/ https://www.ncbi.nlm.nih.gov/pubmed/31428718 http://dx.doi.org/10.1210/js.2019-00148

Ejemplares similares

Effects of KDT501 on Metabolic Parameters in Insulin-Resistant Prediabetic Humans
por: Kern, Philip A., et al.
Publicado: (2017)

OR01-4 Mast Cells and Human Adipose Beiging: Mast Cells Are Recruited to Subcutaneous White Adipose and Degranulate in Response to Cold
por: Kern, Philip, et al.
Publicado: (2019)

Macrophages expressing uncoupling protein 1 increase in adipose tissue in response to cold in humans
por: Finlin, Brian S., et al.
Publicado: (2021)

Mast Cells Promote Seasonal White Adipose Beiging in Humans
por: Finlin, Brian S., et al.
Publicado: (2017)

The Influence of a KDT501, a Novel Isohumulone, on Adipocyte Function in Humans
por: Finlin, Brian S., et al.
Publicado: (2017)

Insulin-resistant subjects have normal angiogenic response to aerobic exercise training in skeletal muscle, but not in adipose tissue
por: Walton, R Grace, et al.
Publicado: (2015)

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
por: Kaji, Kosuke, et al.
Publicado: (2017)

Adipose Tissue Mast Cells Promote Human Adipose Beiging in Response to Cold
por: Finlin, Brian S., et al.
Publicado: (2019)

Pioglitazone does not synergize with mirabegron to increase beige fat or further improve glucose metabolism
por: Finlin, Brian S., et al.
Publicado: (2021)

Improved β-cell function leads to improved glucose tolerance in a transgenic mouse expressing lipoprotein lipase in adipocytes
por: Memetimin, Hasiyet, et al.
Publicado: (2022)

Omega-3 Fatty Acids Reduce Adipose Tissue Macrophages in Human Subjects With Insulin Resistance
por: Spencer, Michael, et al.
Publicado: (2013)

Exploring the Link Between Hepatic Perfusion and Endotoxemia in Hemodialysis
por: Marants, Raanan, et al.
Publicado: (2021)

Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
por: Kaji, Kosuke, et al.
Publicado: (2020)

Human skeletal muscle macrophages increase following cycle training and are associated with adaptations that may facilitate growth
por: Walton, R. Grace, et al.
Publicado: (2019)

Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans
por: Mehta, Nehal N., et al.
Publicado: (2010)

Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin
por: Cianci, Rossella, et al.
Publicado: (2014)

Pioglitazone Treatment Reduces Adipose Tissue Inflammation through Reduction of Mast Cell and Macrophage Number and by Improving Vascularity
por: Spencer, Michael, et al.
Publicado: (2014)

Endotoxemia-mediated activation of acetyltransferase P300 impairs insulin signaling in obesity
por: Cao, Jia, et al.
Publicado: (2017)

Temperature as a Circadian Marker in Older Human Subjects: Relationship to Metabolic Syndrome and Diabetes
por: Harfmann, Brianna D., et al.
Publicado: (2017)

Potassium channel blockade restores the attenuated noradrenaline sensitivity in human endotoxemia
por: Pickkers, P, et al.
Publicado: (2005)

Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans
por: Iqbal, Ahmed, et al.
Publicado: (2018)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans
por: Draper, Amelia, et al.
Publicado: (2018)

Disassociation of Muscle Insulin Signaling and Insulin-Stimulated Glucose Uptake during Endotoxemia
por: Mulligan, Kimberly X., et al.
Publicado: (2012)

Rifaximin Is Effective for the Treatment of Clostridium difficile—Associated Diarrhea: Results of an Open-Label Pilot Study
por: Rubin, David T., et al.
Publicado: (2011)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)

Rifaximin for Pertuzumab-Related GI Toxicities
por: Soyano, Aixa E., et al.
Publicado: (2017)

Postprandial Effect of a High-Fat Meal on Endotoxemia in Arab Women with and without Insulin-Resistance-Related Diseases
por: Al-Disi, Dara A., et al.
Publicado: (2015)

Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish
por: Goh, Boon Chong, et al.
Publicado: (2023)

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity
por: Pimentel, M., et al.
Publicado: (2017)

Microvascular permeability during experimental human endotoxemia
por: van Eijk, L, et al.
Publicado: (2004)

Role and development of GLP-1 receptor agonists in the management of diabetes
por: Chia, Chee W, et al.
Publicado: (2009)

Incretin Therapy and Pancreatic Pathologies: Background Pathology Versus Drug-Induced Pathology in Rats
por: Egan, Josephine M., et al.
Publicado: (2014)

Incretin Therapy and Pancreatic Pathologies: Background Pathology Versus Drug-Induced Pathology in Rats. Diabetes 2014;63:1174–1178
por: Egan, Josephine M., et al.
Publicado: (2014)

Human endotoxemia and human sepsis: limits to the model
por: Anel, Ramon, et al.
Publicado: (2005)

A novel effect of eicosapentaenoic acid: improved diaphragm strength in endotoxemia
por: Calder, Philip C
Publicado: (2010)

Rifaximin for maintenance therapy in antibiotic-dependent pouchitis
por: Shen, Bo, et al.
Publicado: (2008)

The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kl8utb838abahmt062nctjujo4